AAPL 169.89 0.5147% MSFT 399.04 -2.4495% GOOG 157.95 -1.9553% GOOGL 156.0 -1.9669% AMZN 173.67 -1.6535% NVDA 826.32 3.7087% META 441.38 -10.5613% TSLA 170.18 4.9652% TSM 136.58 2.7149% LLY 724.87 -1.0011% V 275.16 0.0509% AVGO 1294.42 2.9917% JPM 193.37 0.1502% UNH 493.86 1.3462% NVO 125.79 -0.2933% WMT 60.21 0.5679% LVMUY 167.91 -2.1618% XOM 121.35 0.2478% LVMHF 837.0 -2.6461% MA 462.11 -0.0843%
Maximus, Inc.
MMS Details
Maximus, Inc. (NYSE: MMS) is a business process services (BPS) company that specialises in the health and human care sectors. Its business segments are 1) The US Services Segment provides a variety of BPS to US state and local government programmes, such as programme administration, appeals, evaluations, and related consulting services. 2) The US Federal Services Segment provides BPS solutions for a wide range of US federal civilian activities, including system and software development and maintenance. 3) Health and disability assessments, programme management for employment assistance, and other job seeker-related services to governments and commercial customers in countries other than the United States are included in the Outside the US Segment.
Latest News:
Q2FY22 Results:
Key Risk:
Outlook:
FY22 Guidance (Source: Q2FY22, Earnings Presentation, May 05, 2022)
Valuation Methodology: EV/Sales Multiple Based Relative Valuation
(Analysis by Kalkine Group)
* % Premium/(Discount) is based on our assessment of the company's FY1 trading multiple after considering its key growth drivers, economic moat, stock's historical trading multiples versus peer average/median, and investment risks.
Stock Recommendation:
MMS' stock price has fallen 22.89% in the past nine months and is currently leaning towards the lower end of its 52-week range of USD 63.20 to USD 94.79. We have valued the stock using the EV/Sales-based relative valuation methodology and arrived at a target price of USD 71.45.
Considering the correction in the stock price, positive outlook, associated risks, and current valuation. We recommend a "Hold" rating on the stock at the closing price of USD 64.62, up 0.37% as of May 16, 2022.
Three-Year Technical Price Chart (May 16, 2022). Source: REFINITIV, Analysis by Kalkine Group
Note 1: The reference data in this report has been partly sourced from REFINITIV.
Note 2: All forecasted figures and industry information have been taken from REFINITIV.
Note 3: The report publishing date is as per the Pacific Time Zone.